Individualised oxygen delivery targeted haemodynamic therapy in high-risk surgical patients: a multicentre, randomised, double-blind, controlled, mechanistic trial.
Ackland GL, Iqbal S, Paredes LG, Toner A, Lyness C, Jenkins N, Bodger P, Karmali S, Whittle J, Reyes A, Singer M, Hamilton M, Cecconi M, Pearse RM, Mallett SV, Omar RZ; POM-O (PostOperative Morbidity-Oxygen delivery) study group.
Ackland GL, et al. Among authors: omar rz.
Lancet Respir Med. 2015 Jan;3(1):33-41. doi: 10.1016/S2213-2600(14)70205-X. Epub 2014 Dec 16.
Lancet Respir Med. 2015.
PMID: 25523407
Clinical Trial.